Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chunbo Dong
Institutions:
Shanxi Agricultural University,
China Pharmaceutical University,
State Key Laboratory of Natural Medicine
Observed institutions:
Shanxi Agricultural University,
China Pharmaceutical University,
Shanxi Medical University,
State Key Laboratory of Natural Medicine,
The University of Texas Southwestern Medical Center
ORCID:
0000-0002-8861-3754
Observed ORCID:
0000-0002-8861-3754
OpenAlex ID:
A5087630978
Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis
2019
·
Jian Qiao
, Zhida Liu
, et al.
·
Cancer Cell
·
191
PDF
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
2020
·
Chuanhui Han
, Zhida Liu
, et al.
·
Nature Immunology
·
160
Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
2021
·
Qian‐Fang Meng
, Yuyue Zhao
, et al.
·
Angewandte Chemie International Edition
·
121
AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
2022
·
Huiyu Li
, Zhida Liu
, et al.
·
Cell Reports Medicine
·
117
Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy
2019
·
Min Luo
, Zhida Liu
, et al.
·
Journal of Controlled Release
·
98
Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3–CD8+ T cells
2020
·
Sisi Deng
, Zhichen Sun
, et al.
·
JCI Insight
·
68
PDF
Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
2019
·
Zhida Liu
, Chuanhui Han
, et al.
·
Science Immunology
·
41
Poly(ethyl ethylene phosphate): Overcoming the “Polyethylene Glycol Dilemma” for Cancer Immunotherapy and mRNA Vaccination
2023
·
Xinyang Yu
, Hongjian Li
, et al.
·
ACS Nano
·
39
Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy
2025
·
Kai Yang
, Bing Bai
, et al.
·
Science Advances
·
36
Advancements in conventional cancer therapy combined with immunotherapy
2024
·
Hongxia Li
, Songyan Han
, et al.
·
Oncology and Translational Medicine
·
36
Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus
2025
·
Weibing Zhang
, Lei Wang
, et al.
·
Frontiers in Immunology
·
11
Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
2021
·
Qian‐Fang Meng
, Yuyue Zhao
, et al.
·
Angewandte Chemie
·
8
Development of a Cellular Membrane Nanovesicle-Based Vaccine Against Porcine Epidemic Diarrhea Virus
2026
·
Xianjun Wang
, Weibing Zhang
, et al.
·
Cells
·
4
PDF
CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXV
2025
·
Jiahao Wu
, Wei Rou
, et al.
·
Cell Reports
·
4
Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
2020
·
Chuanhui Han
, Zhida Liu
, et al.
·
Nature Immunology
·
4
PDF
602 AXL targeting with bemcentinb restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through innate immune cell mediated expansion of TCF1+ CD8 T cells
2021
·
Huiyu Li
, Zhida Liu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
Clinical potential and challenges of extracellular vesicles in myocardial infarction therapy
2026
·
Kaiyi Zhu
, Jing Bai
, et al.
·
Journal of Controlled Release
·
1
Abstract 2752: EGFR tyrosine kinase inhibitor limits tumor relapse through enhancing anti-tumor T cell responses
2018
·
Zhida Liu
, Chuanhui Han
, et al.
·
Cancer Research
Show more works
View as search
Works count:
18
Citation count:
941
H-index:
11
I10-index:
11
Year
Topic
Type